The RAG-1 (recombination activating gene-l) genomic locus, which activates V(O)J recombination when introduced into NIH 3T3 fibroblasts, was isolated by serial genomic transfections of oligonucleotide-tagged DNA. A genomic walk spanning 55 kb yielded a RAG-1 genomic probe that detects a single 6.6-7.0 kb mRNA species in transfectants and pre-B and pre-T cells. RAG-1 genomic and cDNA clones were biologically active when introduced into NIH 3T3 cells. Nucleotide sequencing of human and mouse RAG-1 cONA clones predicts 119 kd proteins of 1043 and 1040 amino acids, respectively, with 90% sequence identity. RAG-1 has been conserved between species that carry out V(O)J recombination, and its pattern of expression correlates exactly with the pattern of expfession of V(O)J recombinase activity. RAG-1 may activate V(O)J recombination indirectly, or it may encode the V(O)J recombinase itself.
Introduction
The enormous number of genes required to encode the subunits of the immunoglobulin (lg) and T cell receptor (TCR) molecules of B and T cells are generated combinatorially in a process known as V(O)J recombination, so called for the variable (V), diversity (D), and joining (J) gene segments used in the recombination process. V(O)J recombination is known to assemble seven different loci in developing lymphocytes: p, K, and h in B cells, and a, p, y, and 6 in T cells (for reviews see Blackwell and Alt, 1988; Davis and Bjorkman, 1988; Raulet, 1989) . The B and T cell lineages appear to share a common V(D)J recombinase (see below) whose expression is tightly regulated during development; recombination of endogenous loci or exogenously introduced substrates occurs only in cells representing the early stages of B and T cell development and does not occur in nonlymphoid cells (Lieber et al., 1987; Schatz and Baltimore, 1988) . V(D)J recombination is also regulated at the level of substrate availability, since loci normally recombined in one cell type are never fully recombined in the other. In some instances, it has been possible to correlate the recombination of a locus with its transcription and increased sensitivity to DNAase I, suggesting that the "accessibility" of a locus to the recombinase may be modulated by its transcription (Yancopoulos and Alt, 1985; Blackwell et al., 1986; Yancopoulos et al., 1986; Schlissel and Baltimore, 1989) .
The &-acting DNA sequences that are necessary and sufficient for V(D)J recombination consist of a palindromic heptamer and AT-rich nonamer separated by a spacer of either 12 or 23 bp (Tonegawa, 1983; Hesse et al., 1989) . Spacer length defines two classes of such recombination signal sequences (RSSs); efficient recombination occurs only when one RSS of each class is involved (the "12-23 joining rule"). RSSs lie directly adjacent to all recombinationally competent V, D, and J gene segments, and their sequences are conserved between the recombining loci and between all species known to carry out V(O)J recombination (Litman et al., 1985a (Litman et al., , 1985b Reynaud et al., 1985; Schwager et al., 1988) . RSSs from different loci and species appear to be functionally interchangeable because they direct proper V(O)J recombination in a variety of host pre-B and pre-T cells (Yancopoulos et al., 1986; Bucchini et al., 1987; Goodhardt et al., 1987; Lieber et al., 1987) . The sequence conservation and functional equivalence of RSSs together provide strong evidence for a single, evolutionarily conserved V(O)J recombinase.
Remarkably little is known, however, about the transacting factors that participate in V(O)J recombination; no factor has yet been demonstrated to be an essential component of the enzyme. V(O)J recombination could be expected to require several distinct enzymatic activities: sequence-specific DNA recognition, endonucleolytic cleavage between the RSS and gene segment, and ligation of the cleaved ends. In addition, because nucleotides are frequently lost and/or added at coding segment junctions, both exonucleolytic and DNA polymerase activities should be associated with the recombinational machinery. It is not known how many factors participate in V(D)J recombination, nor is it known how many are lymphoid specific. We will use the term V(O)J recombinase to refer only to the essential component(s) of the enzyme whose activity is restricted to recombinationally active B and T cells. Thus far, only the enzyme terminal deoxynucleotidyl transferase (TdT) has been implicated in V(D)J recombination, where it is likely to add non-germline-encoded nucleotides (N regions) to the coding junction (Landau et al., 1987) . TdT is not, however, required for V(O)J recombination. Some of the other activities expected to be associated with the recombinase have been detected in nuclear extracts of lymphoid cells-heptamer binding (Aguilera et al., 1987) , nonamer binding (Halligan and Desiderio, 1987) , and endonucleolytic cleavage (Oesiderio and Baltimore, 1984; Hope et al., 1986; Kataoka et al., 1984 )-but the relationship of these factors to V(D)J recombination remains unclear. Finally, a factor critical in V(D)J recombination may be contributed by the gene that is disrupted in the severe combined immunodeficient (SC&) mouse (Bosma et al., 1983) , which is characterized primarily by a defect in recombination of lg and TCR gene segments (Schuler et al., 1986) . (A) Genomic transfection protocol. Genomic DNA and marker plasmid pSVZ-His (which directs expression of the HIS gene) were cotransfected into 3TGR cells, an NIH 3T3 fibroblast line that contains two cop ies of the recombination substrate DGR (DGR and 3TGR have been described in detail in Schatz and Baltimore, 1966) . The transfected cells were selected first in histidinol, for cells that had taken up DNA and were expressing the HIS gene, and then in MPA, which selects for expression of the gpr gene of pDGR. At the bottom is a schematic representation of the relevant portion of pDGR: in its unrearranged configuration (left), the gpf gene cannot be expressed because it lies in opposite transcriptional orientation to the promoter (dashed line); when V(D)J recombination occurs between the V region and one of the two J regions (structure for rearrangement of V to the proximal J is shown at right), the gpf gene is inverted and can then be expressed.
Recombination signal sequences (RSSs) are represented as triangles; the V,21-C gene segment (V) is flanked by an RSS with a 12 bp spacer, and each J,l gene segment (J) is flanked by an RSS with a 23 bp spacer. (6) Lineage of genomic transfectants derived in the oligonucleotide tagging of RAG-I. Genomic DNA from TRX-1 was digested with Xhol and Sall, ligated to the oligonucleotide, and transfected into 3TGR cells to generate the primary transfectant TG-1. TG-1 DNA was digested with Xhol and transfected into 3TGR cells to generate the L and M series of secondary transfectants. Xhol-digested L-4 DNA was used to generate pools of tertiary transfectants 7lA and 7tB.
Previously, we demonstrated that transfer of genomic DNA could induce stable expression of V(D)J recombinase activity in NIH 3T3 fibroblasts, a cell type that normally expresses no such activity (Schatz and Baltimore, 1988) . The results suggested that transfer of a single genetic locus was sufficient for this phenomenon and that this locus might be isolated using serial transfections of genomic DNA.
Using an oligonucleotide marker in conjunction with genomic transfection, we have isolated a gene that stably activates V(D)J recombination in NIH 3T3 cells. The V(D)J recombination activating gene (RAG-l) accomplishes this either by encoding a component of the V(D)J recombinase itself, or by activating other factors that in turn carry out V(D)J recombination.
Results

Oligonucleotide
Tagging of RAG-1 Based on our previous results (Schatz and Baltimore, 1988) , we postulated that expression of a single lymphoidspecific gene could stably activate the V(D)J recombinase in NIH 3T3 fibroblasts. Isolation of this gene using genomic transfection required that the gene be marked or "tagged" in a way that allowed it to be followed through successive rounds of transfection. After several attempts to isolate the human RAG-l gene failed (with human repetitive sequences as the marker), we set out to isolate the mouse gene by tagging it with an oligonucleotide.
Our genomic transfection procedure makes use of the recipient cell line 3TGR, an NIH 3T3 subclone containing two copies of the recombination substrate DGR. DGR allows for the identification of ceils that express V(D)J recombinase activity based on their rearrangement and subsequent expression of the xanthine-guanine phosphoribosyltransferase (gpt) gene of DGR and resulting resistance to the drug mycophenolic acid (MPA; procedure depicted schematically in Figure 1A ). In brief, genomic DNA and a drug resistance gene, histidinol dehydrogenase (HIS), are cotransfected into 3TGR cells, and the ceils are first selected in histidinol (for cells that have taken up DNA and express the HIS gene) and then in MPA. 3TGR cells are killed by MPA because the got gene of DGR is not expressed (it lacks a promoter). However, if V(D)J recombinase activity is expressed in a transfected 3TGR cell, it can recognize the recombination signal sequences present in DGR (which lie adjacent to the V and J segments) and carry out an inversional V-to-J rearrangement event. The inverted gpt gene can now be expressed from the upstream promoter, and the cell becomes resistant to MPA (see Figure 1A) . V-to-J recombination has never been observed in untransfected or control transfected 3TGR cells (rate less than 10-s).
As a source of RAG-l for oligonucleotide tagging, we chose DNA from the genomic transfectant TRX-1, because it had a roughly lo-fold higher specific activity of transfer of V(D)J recombinase activity than any primary DNA tested (S. Latt, D. G. S., and D. B., unpublished data; for the origin of TRX-1, see Schatz and Baltimore, 1988) . This suggested that TRX-1 contained RAG-l in an amplified and/or activated form. TRX-1 was derived by using genomic DNA from a previous transfectant (TR-1) that potentially contained both human (a transfected gene from a human B cell) and mouse (the endogenous, germline alleles from 3TGR cells) RAG-l. Analysis of DNA from TR-1 and TRX-1 strongly suggested that TRX-1 was generated by transfer of mouse RAG-l (Schatz and Baltimore, 1988) . We have confirmed that TRX-1 contains amplified, and perhaps activated, copies of mouse RAG-1 (see below).
Transfection experiments had shown that the restriction enzymes Xhol and Sall did not inactivate mouse RAG-1 (unpublished data). TRX-1 genomic DNA to be tagged with oligonucleotide was first digested to completion with these enzymes, which leave identical 4 nucleotide overhangs at the sites of cleavage, and was then ligated to a large excess of a 30 bp oligonucleotide, which was designed to have Xhol-and Sall-compatible overhangs at either end. Ligation of the oligonucleotide to itself or to the genomic DNA could regenerate Sall sites but not Xhol sites. The ligated mixture of genomic DNA and oligonucleotide was transfected into 3TGR cells, and the cells were subjected to the selection procedure shown in Figure 1A . In the process of ligation and transfection, we hoped that the oligonucleotide would become closely linked to the RAG-1 gene (shown schematically in Figure 2 ).
Of the numerous MPA-resistant colonies that resulted from the primary transfection, we chose two independent clones (TG-1 and TG-2; Figure 1B ) for further analysis.
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Figure 2. Schematic Representation of the Primary and Secondary Transfections
Xhol-and Sall-digested genomic DNA from TRX-1 was ligated to an excess of the oligonucleotide (top; Xhol-Sal1 genomic fragments from TRX-1 represented as striped boxes). The oligonucleotide arrays ("oligo," or "0") did not ligate to the fragment of DNA containing RAG-l (germline RAG-l sequences represented as a thin line); instead, it ligated to other genomic fragments (dashed arrows) and became linked to RAG-I in the primary transfection by cointegration into the chromosome to yield TG-1 (center). The oligonucleotide arrays thereby came to be separated from RAG-1 by a number of irrelevant genomic fragments (striped boxes). Small vertical arrows above the TG-1 chromosome indicate some of the chromosomal breakpoints, where two fragments of DNA, not normally contiguous in the germline, are now juxtaposed. During secondary transfection, the RAG-1 locus, including the flanking blocks of oligonucleotide, was integrated into four independent chromosomal sites (indicated by the flanking dashed lines) in the secondary transfectants L-l. L-4, M-l. and M-3 (bottom) . Relevant sites for the restriction enzyme Bglll (G) as well as the positions of probes AL and AR are shown relative to the right-hand oligonucleotide array (representative of the array in fragment R7.5; see text and Figure  5 ). Between this array and RAG-l. the locus is identical in the four secondary transfectants (identical Bglll fragments detected with probe Ad, while to the right of this oligonucleotide array, the locus differs (different Bglll fragments detected by probe AR). The conserved pattern of hybridization seen with probe AL and divergent pattern seen with probe Aa suggested that RAG-l lay to the left of this oligonucleotide array. The second array of oligonucleotide in transfectants L-4, M-l, and M-3 (to the left of RAG-l) was not present in L-l (see Figure  4 ). Both clones contained normal V-to-J rearrangements of the DGR construct, as shown by Southern blot analysis ( Figure 3) . Furthermore, using a second recombination substrate described previously (Schatz and Baltimore, 1988) , both TG-1 and TG-2 were shown to express V(D)J recombinase activity stably (data not shown). When genomic DNA from TG-1 and TG-2 was digested with restriction enzymes, electrophoresed in an agarose gel, and the gel partially dried and then probed with the oligonucleotide, we observed that both clones contained a large ,.I- Figure 3 . RAG-l Transfectants Contain Normal V-to-J Rearrangements
Genomic DNA was digested with BamHl and Hindlll. electrophoresed through a 0.8% agarose gel, transferred to a Zetabind membrane, and hybridized with radioactive probe 1 (a 1.1 kb fragment of pBR322 that lies just to the right of Jb in DGR; see Schatz and Baltimore, 1988 , for additional details). The diagrams show the structures of the DGR DNA in each of the bands, with the symbols used in Figure 1 . The upper band is derived from unrearranged DGR (3.8 kb), while V-to-J rearrangement yields bands of either 1.9 kb or 1.5 kb. The single band from 3TGR cells is generated by its two unrearranged copies of DGR, while the recombinationally active pre-B cell 3889, infected with DGR and selected in MPA, shows the two bands expected for V-to-J rearrangement. Transfectants show one or both of the bands corresponding to correct V-to-J rearrangement; the slightly different position of the lower band from M2-B is also characteristic of normal V-tc+J rearrangement of DGR (Landau et al., 1987) . GCA and GC-B are MPA' colonies derived from the same transfection of phage clone 12C.2 into 3TGR cells. Human cDNA clones H7 and H36 in expression vector pJ361 and mouse cDNA clone M2 in expression vector CDM8 (see Experimental Procedures) were individually transfected into 3TGR cells to generate the colonies whose DNA is shown in the last four lanes (M2A and M2-B represent MPA'colonies from independent transfections). Marker sizes are shown in kb; exposure = 23 hr.
number of bands that hybridized to the oligonucleotide ( Figure 4 ; data for TG-2 not shown).
To determine if any of the oligonucleotide in TG-1 was closely linked to RAG-l, we performed secondary transfections of Xhol-digested TG-1 DNA into 3TGR cells. Xhol digestion was required to inactivate the rearranged copy of DGR in TG-1, which would otherwise transfer MPA resistance with high efficiency (discussed in Schatz and Baltimore, 1988) . fragment R7.5 represented the same segment of DNA in each transfectant and that, in these four transfectants, this segment of DNA was closely linked to the gene responsible for the activation of the recombinase.
To confirm the tight linkage between R7.5 and RAG-l, Xhol-digested L-4 DNA was transfected into 3TGR cells, and tertiary transfectants were derived ( Figure 16 ). Analysis of pools of tertiary transfectants (7lA and 718) showed that they contained normal V-to-J rearrangements of DGR ( Figure 3 ) and that they contained fragment R7.5 as well as the second oligonucleotide-hybridizing fragment from L-4 (R2.2; Figure 4 ). Thus both R7.5 and R2.2 cosegregated with V(D)J recombinase activity. Since our preparations of genomic DNA typically contained few, if any, fragments larger than 150 kb (data not shown), R7.5 and R2.2 were likely to lie within 150 kb of RAG-l.
The Genomic Walk to RAG-1 As the first step in isolating the genomic sequences encoding RAG-l, we attempted to clone fragment R7.5 by using the oligonucleotide to screen genomic libraries of EcoRI-digested, size-selected M-l DNA (constructed in the bacteriophage vectors hgtl0 and ZAP). When the libraries were grown on standard bacterial host strains, we failed to obtain any positives after screening more than 7 x lo5 recombinants. However, we obtained a single R7.5-containing clone from 1 x lo5 hgtl0 recombinants grown Figure 5 . Genomic Walk to RAG-l
The oligonucleotide was used as a probe to obtain the genomic clone R7.5 (see Experimental Procedures). As described in the text and leg end to Figure 2 , RAG-l was shown to lie to the left of the oligonucleotide in this clone. Probe AL was used to obtain genomic clone 8812. from which probe B was obtained. Repeating this procedure with probes B, C, D, E, and F yielded the additional genomic clones SU.3, SF.2, lOE.1, 15814, and 12C.2 (see Experimental Procedures). Vertical arrows show chromosomal breakpoints encountered during the walk (schematically represented in Figure 2 ). The procedure for detecting the location of sequences linked to RAG-1 in its germline configuration depended on isolating probes from the genomic clones that would de tect non-germline-sized restriction fragments in all genomic transfectams (as did probes F and G; see text). The necessary condition for generation of a non-germline-sized restriction fragment is that the re striction enzyme sites span a chromosomal breakpoint. Genomic clones 9F.2, lOE.1, and 15814 were found to contain a single copy of the marker plasmid pSV2-His (dashed line), which, like the oligonucle otide. became closely linked to RAG-1 by cointegration during the primary transfer&on (see Figure 2 ). on the host strain MB408 (kindly provided by W. Dove), which contains mutations in several bacterial recombination enzymes (Nader et al., 1988) . We subsequently demonstrated that R7.5 and R2.2 each contain a tandem array of 15-30 copies of the oligonucleotide (data not shown); we have been unable to propagate any bacteriophage or plasmid containing these arrays in any strain other than MB408 (in contrast, the DNA sequences from fragment R7.5 that flank this array could be propagated in any bacterial strain tested).
To determine which end of R7.5 lay closest to RAG-l, probes were derived from the left (A3 and right (AR) ends of R7.5 (see Figures 2 and 5) and hybridized to Southern blots containing DNA from the secondary transfectants. Since the transfected RAG-1 locus should be integrated at a different chromosomal site in each independent secondary transfectant (depicted schematically in Figure 2 , bottom), we predicted that, with the RAG-l-distal probe and appropriate restriction enzyme digest, the oligonucleotide-positive secondary transfectants would show different hybridization patterns (e.g., as shown for restriction enzyme Bglll in Figure 2 ) whereas with the RAG-l-proximal probe, these transfectants would have identical patterns of hybridization (i.e., these transfectants should be identical in the direction of RAG-l; see Figure 2 ). In agreement with our predictions, the pattern of bands from these transfectants was identical with probe AL and different with probe An (data not shown), suggesting that RAG-1 lay to the left of the oligonucleotide in R7.5.
Using probe AL and subsequent probes B, C, D, E, and F, we obtained six additional, overlapping genomic clones that provided more than 50 kb of new sequence to the $s left of R7.5 ( Figure 5 ). We investigated each successive genomic clone to discover whether it contained sequences contiguous to RAG-l in its germline configuration (represented by the thin line in Figure 2 ), or whether it contained sequences that only became linked to RAG-1 as a result of ligation or cointegration during the process of transfection (represented as heavy line8 and shaded boxes in Figure 2 ). To answer this question, probe8 from each genomic clone were hybridized to a series of Southern blots containing DNA from 3TGR ceils and a panel of genomic transfectants, which in addition to those described above included several independent primary transfectants derived by transfer of mouse genomic DNA into 3TGR cells (P transfectants). Each P transfectant should contain a different site of integration of germline RAG-1 sequences from that in TRX-1 and all of its derivatives. We reasoned that a probe derived from germline RAG-1 sequences (thin line in Figure 2 ) would, with the appropriate restriction enzyme digest (see legend to Figure 5 for details), detect both a germline band and a transfectant-specific band in TRX-1, its derivatives, and the P transfectants. In contrast, probes derived from outside this region (heavy line8 and shaded boxes in Figure  2 ) would detect two bands in Some or all of the TRX-1 derivatives, but only one band (germline) in the P transfectants. Probes AL, 6, C, D, and E yielded this latter pattern, while probes F and G showed novel, nongermline bands in TRX-1 and all P transfectants tested (data not shown). This implied that clones 15814 and 12C.2 contained sequences linked to RAG-1 in its germline configuration and potentially contained some or all of RAG-1 itself. This procedure also demonstrated that the transfected RAG-l locus was amplified 2-to 5-fold in TRX-1, and most lines derived by transfection of TRX-1 genomic DNA (data not shown). In addition, four chromosomal breakpoints (vertical arrows in Figure 5 ; schematically represented in Figure 2) were detected during the genomic walk, indicating that four normally unlinked fragments of DNA had become integrated between the oligonucleotide in R7.5 and the RAG-1 locus during the primary transfection. A single copy of the pSV2-His marker plasmid was found integrated into one of these breakpoints ( Figure 5 ).
Detection of the RAG-1 mRNA and isolation of RAG-1 cDNAs As an initial screen for RAG-l sequences in genomic clones 15814 and 12C.2, probes F and G ( Figure 5 ) were hybridized to filters containing poly(A)+ RNA from V(D)J recombinase-positive (ret+) and -negative (ret-) cell lines. While probe F gave no detectable hybridization (data not shown), probe G hybridized to a single RNA species, 6.6-7.0 kb in length, present in a ret+ pre-B cell (3889) and in two genomic transfectants (TRX-1 and 16B), but not in a ret-mature B cell (WEH1231) or 3TGR (Figure 6A) . Based on this, we tentatively concluded that this RNA represented the mRNA for RAG-1 and that genomic clone 12C.2 contained a portion of RAG-l.
Probe G was used to screen a mouse pre-B cell (22D6) cDNA library (size selected; 40 positives from lo6 recombinants) and a human pre-B cell (Nalm 6) library (generously provided by D. Kaul and A. Bernards; 11 positives from 2 x lo6 recombinants). Of ten mouse cDNA clones analyzed, the two largest, M6 and M2, contained 6.9 kb and 5.8 kb inserts, respectively, while the largest human cDNA clone8 (H7 and H36) contained 6.6 kb inserts (Figure 7) .
RAG-1 cDNA and Genomic Clones Are Biologically Active To confirm the identity of the genomic and cDNA clones, it was essential to demonstrate that they could activate the V(D)J recombinase when transfected into 3TGR cells, thereby recapitulating the results obtained with genomic DNA. When DNA from phage clone 12C.2 was transfected into 3TGR cells, MPA-resistant colonies were obtained that had carried out normal V-to-J recombination events (Figure 3) . Similar results were obtained when human cDNAs H7 and H36 and mouse cDNA M2, subcloned into mammalian expression vectors, were transfected into 3TGR cells (Figure 3 ). In contrast, no colonies resulted from control transfections of the expression vectors themselves.
This proved that the genomic clone 12C.2, the human cDNA clones H7 and H36, and the mouse cDNA clone M2 were sufficient to activate the V(D)J recombinase and thus that they represented biologically active clones of RAG-l. In all cases, however, cloned DNA was no more active in this assay (number of MPA-resistant colonies) than was an efficient genomic DNA (e.g., from TRX-1). Since 0.1% to 1.0% of cells that took up DNA typically went on to express V(D)J recombinase activity (data not shown), the cloned DNAs were roughly lOO-to 10004old less active than the theoretical maximum. Partial sequencing of genomic clone 12C.2 confirmed that it was mouse in origin and demonstrated that it lacked the 5'end of the gene, including the first lo6 coding nucleotides; its low activity can thus be explained by its need to acquire a promoter (and potentially an in-frame start codon) through fortuitous integration into the host chromosome. We are currently investigating factors that influence expression of RAG-l from the cDNAs.
Pattern of Expression of RAG-1
Using Northern blot analysis, we extended our investigation of the pattern of RAG-l expression to a number of other cell lines and tissues (representative data shown in Figure 6 and summarized in Table 1 ). Comparison of this data with the known pattern of expression of V(D)J recombinase activity (Lieber et al., 1967 ) revealed a striking correlation between RAG-l expression and recombinase activity. The RAG-1 mRNA could be detected only in pre-B and prelr cell lines and not in more mature cells of these Alt et al. (1984) , and Kabat et al. (1967) . The scid pre-B cell lines are described in Hendrickson et al. (1988) lineages ( Figures 6A and 6C ) or in any nonlymphoid cell line tested. Furthermore, RAG-1 mRNA was found in RNA from the thymus, but not in RNA from the brain or spleen ( Figure 6C ), and it could be detected in RNA from a longterm bone marrow culture (kindly provided by K. Denis). Thus, RAG-1 appeared to be expressed only in cells and tissues that carry out V(D)J recombination. A further strong correlation between RAG-l expression and V(D)J recombinase activity came from the late pre-B cell line 7OU3. We reported previously that in a population of 7Oi!/3 cells containing a rearrangement substrate similar to DGR, rare ret+ cells could be isolated that had carried out a V-to-J recombination event (Schatz and Baltimore, 1966) . While RAG-1 mRNA could not be detected in poly(A)+ RNA from the bulk population of 702/3 cells, it could be detected in poly(A)+ RNA from ret+ 70213 cells ( Figure 6B) .
Finally, the patterns of expression of RAG-1 and of the V(D)J recombinase during mouse embryonic development appear to be similar. RAG-1 mRNA could be detected in poly(A)+ RNA from embryos of all stages of development examined, increasing from day 12 to day 16 of gestation ( Figure 6D ). This pattern is consistent with the observation that pre-B cells are first evident in fetal liver at day 11-12 of gestation (Andrew and Owen, 1976; Raff et al., 1976) and that lymphoid cells increase in number in liver and thymus thereafter.
Sequence of the RAG-1 cDNAs We determined the nucleotide sequence of the human cDNA clone H36 (6545 bp, followed by a poly[A] tail) and of the mouse cDNA clone M6 (approximately 7000 nucleotides; no poly[A] tail, two small noncoding regions not sequenced). Both sequences contain a single long open reading frame, which could encode a putative RAG-1 polypeptide of 1043 (human) or 1040 (mouse) amino acids, with a predicted molecular mass of 119 kd (the coding nucleotide sequences and deduced amino acid sequences are shown in Figure 6 ). The nucleotides surrounding the ATG initiator codon at the beginning of each long open reading frame have most of the features of the optimal sequence for eukaryotic translation initiation (ACCmG), including the highly conserved A at position -3, the C at position -1, and the G at position +4 (Kozak, 1964 (Kozak, , 1966 . This ATG triplet is the first found in either sequence and in each case is preceded by an in-frame termination codon. Flanking the long open reading frame in the human and mouse clones are 5' regions of 112 and 94 nucleotides and AT-rich 3' regions of 3.4 and 3.6 kb, respectively (Figure 7) . The mouse and human S'untranslated regions contain 12 and 13 copies, respectively, of the motif AUUUA, which is commonly found in the 3'untrans lated regions of rapid-turnover mRNAs and which may contribute to mRNA instability (Caput et al., 1966; Shaw and Kamen, 1966) .
While the human and mouse nucleotide sequences were not similar to any sequence in the GenBank data base, they are extremely similar to each other: in the putative coding region they are 66% identical, while in the flanking 5' and 3' regions this decreases somewhat to 79% and 66%, respectively. The human and mouse deduced amino acid sequences are 90% identical, and if conservative amino acid replacements are considered, the similarity rises to 95%. The putative proteins contain a high percentage of charged residues (approximately 32%) and contain no lengthy hydrophobic regions. Each sequence contains the positively charged motif, Arg-(140-141)-Lys-Lys-Glu-Lys-Arg, which is similar to the sequences that direct nuclear localization in a number of other proteins (Lanford et al., 1968 ; for review see Gerace and Burke, 1966) . Finally, when the National Biomedical Research Foundation protein sequence library was searched with the deduced amino acid sequences, the only suggestive homology discovered was to the DNA binding domain of the human, rat, and mouse glucocorticoid receptors (for review see Beato, 1969) . When gaps were introduced to maximize alignment, these regions (mouse RAG-l residues 263-332, human alpha glucocorticoid receptor residues 432-481) are almost 37% identical, including identities at all seven of the cysteine residues in this region of the human glucocorticoid receptor; however, the spacing between cysteine residues is not conserved between the two proteins. This degree of relatedness is statistically significant (Needleman-Wunsch similarity value greater than 6 standard deviation units above the mean of 100 shuffled sequences; Dayhoff et al., 1978; Doolittle, 1981) and suggests that RAG-1 may encode a metal binding protein.
RAG-1 Is Evolutionarily Conserved
The high degree of similarity of the human and mouse RAG-1 nucleotide sequences led us to examine if RAG-1 might be conserved in other species known to carry out V(D)J recombination. Probe XH700, derived from the human cDNA (Figure 7 ) detected a single band in rabbit, dog, goat, and horse DNA of roughly equal intensity to the band detected in mouse DNA ( Figure 9A ) and, at a somewhat reduced stringency, also detected a small number of bands in chicken and frog DNA ( Figure 9B ). We conclude that RAG-1 coding sequences are conserved in a wide range of species that carry out V(D)J recombination.
Discussion
We describe in this report the isolation and initial characterization of a novel participant in the lymphoid-specific activation of V(D)J recombination, the recombination activating gene-l (RAG-l). Genomic sequences containing RAG-l were isolated by virtue of their ability to activate V(D)J recombination when introduced into NIH 3T3 fibroblasts. An oligonucleotide marker allowed us to identify the genomic locus containing RAG-l by virtue of the cosegregation of V(D)J recombinase activity and arrays of the oligonucleotide. The oligonucleotide subsequently served as an initial hybridization probe in a genomic walk that ended within RAG-1 sequences. RAG-1 genomic sequences were used to isolate human and mouse RAG-l cDNAs; proof of the identity of the genomic and cDNA clones came with the demonstration that each was sufficient to activate expression of the V(D)J recombinase. RAG-l mRNA could not be detected in nonlymphoid cell lines or tissues, but was detected only in ceil lines representing the early stages of B and T cell development and in thymus and bone marrow. Thus, tight regulation of its expression would appear to confine RAG-1 activity to cell lines and tissues that express V(D)J recombinase activity. Nucleotide sequencing revealed that the mouse and human RAG-1 cDNAs are extremely similar, each with a long open reading frame in the 5' half that could encode a 119 kd polypeptide. We discuss below the potential roles of this putative protein in the process of lymphoid development, and also comment on the unusual aspects of the means by which the gene was isolated.
Isolation of RAG-1 by Genomic Tiansfection Our results arising from transfection of exogenously tagged genomic DNA are comparable to those of others who have isolated genes by this means, with the notable exception that the oligonucleotide marker was found to lie more than 40 kb from our target gene and to be separated from it by several noncontiguous genomic fragments (see Figures 2 and 5 ). Ligation of plasmid or tRNA markers to restriction enzyme-digested genomic DNA, followed by transfection, has yielded direct juxtapostion of the marker and the germline fragment carrying the target gene (Goldfarb et al., 1982; Lowy et al., 1980; Perucho et al., 1980) . The most likely explanation for this difference lies in the size of the genomic restriction fragment that contains the target gene and is available for ligation to the marker. While in the examples cited above the target genes were ligated to the marker as small (less than 8 kb) Hindlll fragments, RAG-1 from TRX-1 was contained on a Xhol-Sal1 fragment of at least 50 kb, and perhaps much larger (data not shown). If the RAG-l-containing Xhol-Sall fragment were larger than 100-150 kb, the restriction sites would almost certainly have been sheared away from the RAG-1 gene during preparation of the DNA, making subsequent ligation to the oligonucleotide unlikely. Successful tagging of RAG-1 would then require cointegration of the oligonucleotide and RAG-l, as depicted in Figure 2 , generating an unpredictable amount of intervening DNA. Use of an oligonucleotide as a marker has the advantages that it can be used in vast molar excess in the ligation to genomic DNA and can be engineered to contain convenient cohesive ends and restriction sites. This procedure, however, has one potential disadvantage: if multimerization of the oligonucleotide is allowed during the ligation, large tandem arrays can be generated that are subsequently difficult to propagate in bacteria, making isolation of sequences flanking the arrays arduous. The bacterial strain MB408, one of a series of strains designed to tolerate DNA repeat systems and function efficiently with the phage vector hgtl0 (Nader et al., 1988) , allowed cloning of two oligonucleotide arrays (R7.5 and R2.2; data not shown for R2.2) that could not be propagated in a number of other strains.
Characterization of human RAG-1 cDNA clones provided a simple explanation for our failure to isolate human RAG-1 genomic sequences by genomic transfection: all The nucleotide sequences of the 5' half of the mouse cDNA clone M8 and the human cDNA clone H38 are shown in the top and bottom rows of each line (identical residues indicated by a dash in the human sequence). The mouse and human sequences shown include the 5' untranslated regions (94 and 112 nucleotides, respectively), the entire coding regions, and a small portion of the 3'untranslated regions. Nucleotides are numbered beginning with the first nucleotide of the cDNA. The predicted mouse and human RAG-1 amino acid sequences (1040 and 1043 amino acids, respectively) are given between the nucleotide sequences (identities indicated by asterisks in the human sequence). Two gaps have been introduced into the mouse coding sequence (nucleotide positions 242 and 824) to maximize alignment. The putative nuclear localization signal and the seven cysteine residues in the region with homology to the glucocorticoid receptor are underlined. The first nucleotide of the genomic clone 12C.2 (nucleotide 201) is indicated by * ; probe G is colinear with the mouse cDNA and extends from nucleotide 201 to the Bglll site at position 879 (see Figure 7) . While the human cDNA clone H38 has been shown to be biologically active (see text and Figure 3) , the mouse cDNA clone M8 has not. human cDNA clones examined contained a Xhol restriction site in the putative coding region of the gene (while the mouse cDNAs do not), thus making transfer of an active human gene using Xhol-digested genomic DNA extremely unlikely.
RAG-l: Recombinase or Developmental Switch? We propose two alternative models for the mechanism of action of the factor encoded by RAG-l: it might participate directly in enzymatic steps of V(D)J recombination, or it might function as a regulatory molecule in a pathway leading to the activation of the recombinase. If the former model is correct, then the factor encoded by RAG-1 will represent the first component of the V(D)J recombinase to be isolated. Analysis of RAG-1 should then provide insights into the molecular mechanism of V(D)J recombination and its regulation during lymphoid development, and expression of RAG-l might allow development of an in vitro V(D)J recombination system. If the latter model is correct, then RAG-1 should play an important role in the early development of B and T cells, and study of this gene might provide direct insight into the regulation of expression of V(D)J recombinase activity.
Some properties of the putative RAG-1 polypeptide are equally compatible with either model. It is a large polypeptide with a predicted unmodified molecular mass of 119 kd, and contains the potential nuclear localization signal Arg-Lys-Lys-Glu-Lys-Arg and a cysteine-rich domain with similarity to the zinc finger DNA binding domain of glucocorticoid receptors. Thus RAG-l may encode a nuclear protein with metal and DNA binding activities.
Other properties of RAG-l provide weak and circumstantial evidence in favor of the recombinase model. The high degree of conservation of RSSs through evolution and the functional equivalence of RSSs from a variety of species and recombining loci have together supplied strong support for the notion of a single, evolutionarily conserved V(D)J recombinase. Consistent with this, RAG-1 appears to be conserved between a number of species known to carry out V(D)J recombination, including rabbit, dog, goat, horse, chicken, and frog ( Figure 9 ). In addition, RAG-1 expression correlates precisely with V(D)J recombinase activity, as examined in cell lines, tissues, the developing embryo, and the unusual, RAG-1-"negative" pre-B cell line 70213, where the rare cells expressing detectable recombinase activity also express RAG-l ( Figure  6 and Table 1) .
Other results argue weakly against the model of RAG-l as a regulator of a developmental pathway leading to the expression of V(D)J recombinase activity. In addition to activating the recombinase, such a regulator might have more pleiotropic effects, and NIH 3T3 fibroblasts expressing RAG-l might then exhibit other features characteristic of early lymphocytes. We have been unable to detect such lymphoid-specific properties: transfectants stably expressing RAG-l have the morphology and growth requirements typical of adherent, fibroblastoid cells (data not shown); they do not express the B lineage surface marker 8220 (Coffman and Weissman, 1981 ; data not shown), they do not express detectable levels of TdT mRNA (S. Smale, personal communication), nor do they contain detectable amounts of RNA or protein corresponding to the B lymphocyte-specific octamer binding factor NF-A2 (Staudt et al., 1988; L. Corcoran and L. Staudt, personal communication) ; finally, they fail to rearrange their endogenous immunoglobulin TV or K loci, as assayed by a highly sensitive polymerase chain reaction assay (M. Schlissel, personal communication) , and also do not rearrange their endogenous T cell receptor 6 locus, as assayed by Southern blotting (data not shown). Thus, RAG-l does not appear to be functionally analogous to the MyoDl or myd genes, which in triggering the myogenic conversion of C3H lOTl12 cells stimulate the coordinate activation of many muscle-specific genes and induce a series of gross morphological alterations (Lassar et al., 1986; Pinney et al., 1988) . If RAG-1 were to function in a developmental pathway leading to the expression of the V(D)J recombinase, it would be predicted to occupy a position in the pathway just "upstream" of the recombinase in both the B and T cell lineages. In addition, with the exception of the weak homology to the DNA binding domain of the glucocorticoid receptor, the putative RAG-l protein contains no significant sequence similarity to any transcription factor for which sequence data is available (for review see Mitchell and Tjian, 1989) .
In sum, while neither the recombinase model nor the developmental regulator model is contradicted by the available data, the indirect evidence leads us to favor the hypothesis that RAG-1 encodes some or all of the V(D)J recombinase (where "V(D)J recombinase" refers to the essential, lymphoid-specific component(s) of the enzymatic machinery of recombination).
RAG-1 and the Enzymology of V(D)J Recombination
Detailed mechanistic studies of prokaryotic site-specific recombination systems have revealed that a number of recombinases recruit accessory host factors as obligatory or stimulatory participants in the recombination reaction (Weisberg and Landy, 1983; Huber et al., 1985; Johnson and Simon, 1985; Kahmann et al., 1985) . This may also be true for the V(D)J recombinase, which carries out a highly complex site-specific recombination reaction. The reaction requires coordinate recognition of RSSs that may be hundreds of kilobase pairs apart, cleavage between the RSSs and their flanking gene segments, and ligation of the cleaved ends. Before the ends of the coding segments are joined, they may be subjected to exonucleolytic digestion and/or addition of new residues. A number of factors with various binding (Aguilera et al., 1987; Halligan and Desiderio, 1987) or endonucleolytic (Desiderio and Baltimore, 1984; Kataoka et al., 1984; Hope et al., 1986) activities have been detected in nuclear extracts from lymphoid cells, but their relationship to the V(D)J recombinase, or to RAG-l, remains obscure. The V(D)J recombinase appears to recruit the enzyme TdT as a nonessential accessory factor, where it is likely to function in the addition of N regions to the coding junction.
V(D)J recombination may also involve the product of the gene that is mutant in the scid mouse. In the scid mouse, a recessive mutation on chromosome 16 (Bosma et al., 1989 ) causes a severe deficiency in mature S and T cells by disrupting normal V(D)J recombination (Schuler et al., 1986) . The V(D)J recombinase of scid lymphocytes cannot form proper coding junctions (Lieber et al., 1988) . but instead introduces large deletions (Hendrickson et al., 1988; Schuler et al., 1986) . TheseTesults have prompted the hypothesis that the mutant scid gene encodes a central component of the recombinase. It was thus particularly important to determine the relationship between RAG-l and the scid gene. Hybridization of a RAG-1 probe to Southern blots containing DNA from a variety of somatic cell hybrids (kindly provided by f? D'Eustachio) demonstrated that RAG-1 does not map to mouse chromosome 16 (data not shown), establishing that RAG-1 and the scid gene are different genes. However, scid myeloid and fibroblastoid cells may have an increased sensitivity to radiation-induced damage (Phillips and Fulop, 1989) , implying that the scid defect may not be confined to lymphoid cells. The simplest interpretation of this result is that the scid gene does not encode the V(D)J recombinase, but rather encodes a ubiquitously expressed factor involved both in V(D)J recombination and in the repair of chromosomal damage.
The prokaryotic recombination systems cited above are examples of recombinases with multiple enzymatic activities that also recruit accessory factors in order to carry out efficient recombination. While V(D)J recombination is a complex process requiring at least three distinct enzymatic activities-RSS recognition, endonucleolytic cleavage, and ligation-there is ample precedent for the supposition that RAG-l also encodes such a recombinase.
Experimental Procedures Genomic Transfection
The recombination substrate pDGR and cell lines 3TGR and TRX-1 have been described previously (Schatz and Baltimore, 1968) . Our previous procedure for genomic transfection (Schatz and Baltimore, 1988) was modified to allow for efficient transfection of unsheared, high molecular weight genomic DNA. Genomic DNA (80 pg) and linearized pSV2-His plasmid (2.5 pg) were combined in a final volume of 0.5 ml water, and an equal volume of 0.5 M Car& was added. The DNA-Ca mixture was then immediately added in a dropwise fashion to 1 ml of HNP buffer with continuous gentle vortexing. HNP buffer (IO ml) was prepared just before use from 9.8 ml of 50 mM HEPES (pH 7.10), 280 mM NaCI, and 0.2 ml of 70 mM Na2HP04 (pH 7.10). The precipitate was allowed to form for 3-8 min and was then added to two 10 cm dishes of 3TGR cells that had previously been refed with 5 ml of medium (DMEM supplemented with 10% calf serum and penicillin-streptomycin sulfate). L-histidinol and MPA drug selections were carried out as described previously (Schatz and Baltimore, 1988) , with the exception that MPA selection was carried out in the presence of 500 PM L-histidinol in medium lacking histidine. All transfectants were routinely propogated under continuous MPA-histidinol double selection.
Ligation of Oligonucleotide
to Genomic DNA Two 30 base oligonucleotides (Tl: 5'TCGACATCGCGAACGCATCGTG-TTCTAGAG-3'and T2: Y-TCGACTCTAGAACACGATGCGTTCGTTCGCGATG-31, were synthesized, annealed, and phosphorylated with polynucleotide kinase. TRX-1 genomic DNA (80 pg), digested to completion with Xhol and Sall, was ligated to 12.5 pg of the annealed, phosphorylated oligonucleotide in a 250 VI volume with 1800 U of T4 DNA ligase (New England Biolabs) for 13 hr at 15°C.
Oligonucleotide
Hybrldlzatlon in Dried Agarose Gels Our procedure for hybridization of an oligonucleotide to DNA in a partially dried agarose gel has been reported in detail elsewhere (Schatz, 1989) . In brief, restriction enzyme-digested genomic DNA was electrophoresed in a 0.8% agarose gel, and the gel was soaked for 45 min in denaturation solution (1.5 M NaCI, 0.5 M NaOH) and then for 30 min each in neutralization solution (1.5 M NaCI, 0.5 M Tris-HCI [pH 7.51) and water. The gel was partially dried on a conventional gel dryer and prehybridized and hybridized in lx SSC (0.15 M NaCI, 15 mM sodium citrate [pH 7.4]), 20 mM NaHzPO,, 5x Denhardt's solution [lx Denhardt's = 0.02% Ficoll400,0.02% polyvinyl pyrrolidone, 0.02% bovine serum albumin]), 250 pg/ml sonicated salmon sperm DNA, 0.1% SDS at 56OC. Single-stranded oligonucleotide Tl, phosphorylated to high specific activity with polynucleotide kinase (Eoehringer Mannheim) and [Y-~P~ATP, was used in the hybridization at 5 x 106 cpmlml. The gel was washed first in 6x SSC at room temperature and then increasingly stringently, with final wash conditions being 0.5x SSC, 0.1% SDS at 56OC. The gel was again partially dried and exposed at -80°C to X-ray film backed by an intensifying screen.
Southern and Northern Gel Transfer Hybridization
Probes were labeled with [@P]dCTP using the hexamer labeling method (Feinberg and Vogelstein, 1983) . Southern blotting was carried out as described previously (Schatz and Baltimore, 1988) . Probe 1 was a 1.1 kb Nrul-Pvull fragment of pBR322. Probe G was a 678 bp fragment from the left end of genomic clone 12C.2 (colinear with mouse cDNA nucleotides 201 to 879; Figure 8 ). Probe XH700 was a 908 bp Xhol-Hindlll fragment corresponding to human cDNA nucleotides 2273 to 3181.
RNA samples were electrophoresed in 2.2 M formaldehyde-l% agarose gels (Maniatis 81 al., 1982 ) and transferred to nitrocellulose or Hybond-C extra (Amersham) membranes. RNA loading was evaluated by hybridization with a y-actin probe derived as a BamHI-Hind Ill fragment from plasmid pSRG y-actin (Enoch et al., 1988) .
All blots were exposed at -8OOC to X-ray film backed by an intensifying screen.
Genomic and cDNA Libraries Genomic clones were obtained from five different libraries: clone R7.5 from EcoRI-digested M-l genomic DNA in a 6.0-9.0 kb size-selected hgtl0 (Stratagene) library; clone 8812 from BarnHI-digested M-l genomic DNA in a IO-14 kb size-selected LEMBL-3 (Promega) library; clones 9U.3, 9F.2, and 10E.l from partially SauSa-digested L-4 genomic DNA in a I.EMBL-3 library; clone 15814 from BarnHI-digested L-4 genomic DNA in a 12-20 kb size-selected AFix (Stratagene) library; and clone 12C.2 from partially Sauda-digested L-4 genomic DNA in a lFix library. Libraries were constructed according to the protocols provided by the suppliers of the bacteriophage arms and were propagated in standard bacterial strains, with the exception of the lgtl0 library that yielded clone R7.5, which was grown in bacterial strain MB408 (rack-, rec821, m&22, sbcB15, hflA. hfls, hsdR-, and tet'; Nader et al., 1986) .
A cDNA library was prepared from poly(A)+ RNA from the Abelson murine leukemia virus-transformed cell line 22D6 (Alt et al., 1981) by the method of Gubler and Hoffman (1963) , except that first-and second-strand reactions were carried out in a single tube, without intervening extractions or precipitations (Sartoris et al., 1987) . cDNA was ligated to EcoRI-Notl adaptors (Invitrogen) and size fractionated by agarose gel electrophoresis. After glass powder purification (Vogelstein and Gillespie, 1979) , the 2.0-8.0 kb size fraction was ligated to IgtlO. Probe G was used to screen 1 x 106 unamplified recombinants, and IO of the 40 positives were analyzed further. The two largest cDNA inserts, M6 (7.0 kb) and M2 (5.8 kb), were excised with Notl and subcloned into the Notl site of pBSK+ (Stratagene) and into the eukaryotic expression vector CDM8 using &Xl adaptors (Seed, 1987) .
Recombinants (2 x 106) from a human pm-B cell (Nalm 6) cDNA library, constructed in the bacteriophage vector UP (Stratagene) by D. Kaul and A. Bernard& were screened with probe G to yield 11 positive plaques. pBSK-plasmids containing the three largest cDNA inserts, H7 and H36 (6.8 kb) and H34 (8.0 kb), were isolated directly from bacteria containing )Lu\P bacteriophage using helper phage R408, following the protocol supplied by Stratagene for in vivo excision. The H7 and H36 cDNA inserts were excised as BamHI-Clal fragments and subcloned into the BamHI-Clai sites of the polylinker of the eukaryotic expression vector pJ3G, provided by Jay Morgenstern (Whitehead Institute, MIT), a vector that directs expression under the control of the SV40 early-region promoter.
Ten microgram samples of DNA from genomic clone 12C.2, human cDNA clones H7 and H36 in pJ3D, or mouse cDNA clone M2 in pCDM8 were separately cotransfected with 2 pg of linearized pSV2-His into 3TGR ceils using the genomic transfection protocol outlined above.
Nucleotide Sequence Analysis
The Erase-a-Base (exonuclease Ill) system of Promega was used to generate nested deletions of both strands of mouse cDNA clone M6 and of one strand each of human cDNA clones H36 and H3-4 (which lay in opposite orientation in the pBSK-vector). Deleted templates were transformed into JMl09 (Stratagene), and single-stranded DNA was isolated using helper phage VCSM13 (Stratagene). Singlestranded templates were sequenced by dideoxy chain termination (Sanger et al., 1977) using Sequenase DNA polymerase and the protocol supplied by the manufacturer (United States Biochemical Corp.). The complete nucleotide sequence of both strands was determined in the 5'half of each cDNA, which included the region containing the long open reading frame. The complete sequence of the human 3' region was determined, although in several small regions sequence was obtained from only one strand. The mouse 3' region was entirely sequenced except for two small gaps, approximately 200-250 nucleotides in total length. Nucieotide and predicted amino acid sequences have been submitted to GenBank and Protein Identification Resource/NBRF, respectively.
Using the FASTA algorithm (Pearson and Lipman. 1988) . the human and mouse RAG-1 nucleotide sequences were compared with the GenBank nucleic acid data base, and the predicted amino acid sequences were compared with the National Biomedical Research Foundation protein sequence data base. In addition, the mouse amino acid sequence was compared with the potential translation products of the GenBank nucleic acid data base, using a modification the FASTA algorithm. The degree of statistical significance of the similarities detected was investigated using the random shuffling algorithm (Dayhoff et al., 1978; Doolittle, 1981) of the program IALIGN (Dayhoff et al., 1983) .
